Quipt Home Medical Corp. (QIPT)
USD 2.02
(-8.18%)
USD 2.02
(-8.18%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 18.32 Million USD | 17.59% |
| 2022 | 15.58 Million USD | 68.43% |
| 2021 | 9.25 Million USD | 44.76% |
| 2020 | 6.39 Million CAD | 78.59% |
| 2019 | 3.57 Million CAD | -18.01% |
| 2018 | 4.36 Million CAD | -44.67% |
| 2017 | 7.88 Million CAD | 27.41% |
| 2016 | 6.19 Million CAD | 14.82% |
| 2015 | 5.39 Million CAD | 363.02% |
| 2014 | 1.16 Million CAD | 108.46% |
| 2013 | 558.75 Thousand CAD | 3086.86% |
| 2012 | 17.53 Thousand CAD | -75.29% |
| 2011 | 70.94 Thousand CAD | 182.36% |
| 2010 | 25.12 Thousand CAD | 337.31% |
| 2009 | 5745.29 CAD | -59.24% |
| 2008 | 14.09 Thousand CAD | -48.38% |
| 2007 | 27.3 Thousand CAD | -80.96% |
| 2006 | 143.38 Thousand CAD | 14338800.0% |
| 2005 | 1.00 CAD | 0.0% |
| 2004 | 1.00 CAD | 0.0% |
| 2003 | 1.00 CAD | -100.0% |
| 2002 | 25.93 Thousand CAD | 27.66% |
| 2001 | 20.31 Thousand CAD | -20.88% |
| 2000 | 25.68 Thousand CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 19.61 Million USD | 7.08% |
| 2024 Q2 | 22.42 Million USD | 13.84% |
| 2024 Q3 | 22.59 Million USD | 0.69% |
| 2023 Q2 | 20.37 Million USD | 20.82% |
| 2023 Q1 | 16.86 Million USD | 8.22% |
| 2023 Q3 | 19.44 Million USD | -4.55% |
| 2023 Q4 | 18.32 Million USD | -5.78% |
| 2023 FY | 18.32 Million USD | 17.59% |
| 2022 FY | 15.58 Million USD | 68.43% |
| 2022 Q1 | 9.84 Million USD | 6.41% |
| 2022 Q4 | 15.58 Million USD | 17.72% |
| 2022 Q2 | 11.78 Million USD | 19.64% |
| 2022 Q3 | 13.23 Million USD | 12.39% |
| 2021 Q1 | 7.8 Million USD | 22.14% |
| 2021 FY | 9.25 Million USD | 44.76% |
| 2021 Q4 | 9.25 Million USD | -15.22% |
| 2021 Q3 | 10.91 Million USD | 10.79% |
| 2021 Q2 | 9.85 Million USD | 26.18% |
| 2020 Q4 | 6.39 Million CAD | 4.5% |
| 2020 FY | 6.39 Million CAD | 78.59% |
| 2020 Q3 | 6.11 Million CAD | 11.1% |
| 2020 Q1 | 4.83 Million CAD | 35.01% |
| 2020 Q2 | 5.5 Million CAD | 13.94% |
| 2019 Q2 | 5.68 Million CAD | 16.15% |
| 2019 Q3 | 4.85 Million CAD | -14.58% |
| 2019 Q4 | 3.57 Million CAD | -26.28% |
| 2019 FY | 3.57 Million CAD | -18.01% |
| 2019 Q1 | 4.89 Million CAD | 12.1% |
| 2018 Q3 | 4.42 Million CAD | -39.92% |
| 2018 Q1 | 8.05 Million CAD | 2.08% |
| 2018 FY | 4.36 Million CAD | -44.67% |
| 2018 Q2 | 7.36 Million CAD | -8.52% |
| 2018 Q4 | 4.36 Million CAD | -1.37% |
| 2017 Q1 | 6.44 Million CAD | 4.02% |
| 2017 Q4 | 7.88 Million CAD | 17.57% |
| 2017 Q3 | 6.71 Million CAD | -0.64% |
| 2017 Q2 | 6.75 Million CAD | 4.85% |
| 2017 FY | 7.88 Million CAD | 27.41% |
| 2016 Q1 | 6.5 Million CAD | 20.59% |
| 2016 Q3 | 6.94 Million CAD | 7.24% |
| 2016 Q4 | 6.19 Million CAD | -10.86% |
| 2016 FY | 6.19 Million CAD | 14.82% |
| 2016 Q2 | 6.47 Million CAD | -0.4% |
| 2015 Q3 | 3.86 Million CAD | 49.09% |
| 2015 Q4 | 5.39 Million CAD | 39.62% |
| 2015 Q2 | 2.59 Million CAD | 68.66% |
| 2015 FY | 5.39 Million CAD | 363.02% |
| 2015 Q1 | 1.53 Million CAD | 31.89% |
| 2014 Q2 | 771.4 Thousand CAD | 58.72% |
| 2014 Q3 | 978.43 Thousand CAD | 26.84% |
| 2014 Q4 | 1.16 Million CAD | 19.04% |
| 2014 Q1 | 485.99 Thousand CAD | -13.02% |
| 2014 FY | 1.16 Million CAD | 108.46% |
| 2013 FY | 558.75 Thousand CAD | 3086.86% |
| 2013 Q1 | 30.69 Thousand CAD | 75.08% |
| 2013 Q4 | 558.75 Thousand CAD | 100.23% |
| 2013 Q3 | 279.06 Thousand CAD | 390.72% |
| 2013 Q2 | 56.86 Thousand CAD | 85.26% |
| 2012 Q4 | 17.53 Thousand CAD | -64.49% |
| 2012 FY | 17.53 Thousand CAD | -75.29% |
| 2012 Q2 | 74.12 Thousand CAD | -69.93% |
| 2012 Q1 | 246.51 Thousand CAD | 247.49% |
| 2012 Q3 | 49.37 Thousand CAD | -33.4% |
| 2011 FY | 70.94 Thousand CAD | 182.36% |
| 2011 Q4 | 70.94 Thousand CAD | -59.73% |
| 2011 Q3 | 176.18 Thousand CAD | 37.22% |
| 2011 Q2 | 128.39 Thousand CAD | 81.91% |
| 2011 Q1 | 70.58 Thousand CAD | 180.92% |
| 2010 Q4 | 25.12 Thousand CAD | 0.0% |
| 2010 Q1 | 6369.97 CAD | 2.08% |
| 2010 FY | 25.12 Thousand CAD | 337.31% |
| 2010 Q2 | 6543.06 CAD | 2.72% |
| 2009 Q2 | 8859.59 CAD | -3.62% |
| 2009 Q3 | 5745.29 CAD | -35.15% |
| 2009 Q1 | 9192.28 CAD | -6.97% |
| 2009 Q4 | 6240.06 CAD | 8.61% |
| 2009 FY | 5745.29 CAD | -59.24% |
| 2008 Q4 | 9880.97 CAD | -29.89% |
| 2008 Q1 | - CAD | -100.0% |
| 2008 Q3 | 14.09 Thousand CAD | 704600.0% |
| 2008 Q2 | 2.00 CAD | 0.0% |
| 2008 FY | 14.09 Thousand CAD | -48.38% |
| 2007 Q2 | 159.12 Thousand CAD | 15912600.0% |
| 2007 Q1 | 1.00 CAD | -100.0% |
| 2007 Q4 | 1.00 CAD | -100.0% |
| 2007 FY | 27.3 Thousand CAD | -80.96% |
| 2007 Q3 | 27.3 Thousand CAD | -82.84% |
| 2006 Q1 | 0.71 CAD | -44.93% |
| 2006 Q4 | 140.24 Thousand CAD | -2.19% |
| 2006 FY | 143.38 Thousand CAD | 14338800.0% |
| 2006 Q2 | -0.46 CAD | -165.77% |
| 2006 Q3 | 143.38 Thousand CAD | 30841949.19% |
| 2005 FY | 1.00 CAD | 0.0% |
| 2005 Q1 | 1.00 CAD | 858993459100.0% |
| 2005 Q2 | 88.77 Thousand CAD | 8877200.0% |
| 2005 Q4 | 1.28 CAD | 28.36% |
| 2005 Q3 | 1.00 CAD | -100.0% |
| 2004 Q4 | - CAD | -100.0% |
| 2004 Q1 | 1420.45 CAD | 141945.24% |
| 2004 FY | 1.00 CAD | 0.0% |
| 2004 Q2 | 1404.80 CAD | -1.1% |
| 2004 Q3 | 1.00 CAD | -99.93% |
| 2003 Q3 | 1.00 CAD | -100.0% |
| 2003 Q2 | 26.73 Thousand CAD | 7.14% |
| 2003 FY | 1.00 CAD | -100.0% |
| 2003 Q1 | 24.95 Thousand CAD | -0.08% |
| 2003 Q4 | 1.00 CAD | 0.0% |
| 2002 Q1 | 33.53 Thousand CAD | -0.52% |
| 2002 FY | 25.93 Thousand CAD | 27.66% |
| 2002 Q4 | 24.97 Thousand CAD | -3.72% |
| 2002 Q3 | 25.93 Thousand CAD | -22.69% |
| 2002 Q2 | 33.55 Thousand CAD | 0.05% |
| 2001 FY | 20.31 Thousand CAD | -20.88% |
| 2001 Q4 | 33.71 Thousand CAD | 0.0% |
| 2000 FY | 25.68 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -453.648% |
| BrainsWay Ltd. | 3.71 Million USD | -393.025% |
| Cerus Corporation | 39.86 Million USD | 54.034% |
| Envoy Medical, Inc. | 1.4 Million USD | -1205.252% |
| electroCore, Inc. | 2.16 Million USD | -748.414% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -3910.01% |
| IceCure Medical Ltd | 2.27 Million USD | -705.527% |
| Inogen, Inc. | 21.84 Million USD | 16.091% |
| OrthoPediatrics Corp. | 105.85 Million USD | 82.687% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -6491.995% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -1832574400.0% |
| MaxCyte, Inc. | 12.22 Million USD | -49.855% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -961.325% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -11615.73% |
| Orthofix Medical Inc. | 222.16 Million USD | 91.751% |
| PAVmed Inc | 1.01 Million USD | -1701.943% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | 8.192% |
| RxSight, Inc. | 17.42 Million USD | -5.193% |
| Sight Sciences, Inc. | 7.84 Million USD | -133.479% |
| SI-BONE, Inc. | 20.24 Million USD | 9.498% |
| TELA Bio, Inc. | 13.16 Million USD | -39.232% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | 37.337% |
| Vivos Therapeutics, Inc. | 1.00 USD | -1832574400.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -328.372% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -7867.715% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -677.833% |
| CVRx, Inc. | 10.98 Million USD | -66.856% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -4597.993% |
| Bioventus Inc. | 91.33 Million USD | 79.935% |
| Venus Concept Inc. | 28.67 Million USD | 36.094% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -620.069% |
| LivaNova PLC | 147.88 Million USD | 87.608% |
| 908 Devices Inc. | 14.93 Million USD | -22.679% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 86.608% |
| Nemaura Medical Inc. | 1.75 Million USD | -944.29% |
| NeuroPace, Inc. | 11.21 Million USD | -63.418% |
| LENSAR, Inc. | 15.68 Million USD | -16.806% |
| Apyx Medical Corporation | 9.92 Million USD | -84.679% |
| Cutera, Inc. | 72.1 Million USD | 74.583% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -585.587% |
| BioSig Technologies, Inc. | -103 Thousand USD | 17891.985% |
| Anika Therapeutics, Inc. | 46.38 Million USD | 60.493% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -131.649% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 95.296% |
| Axonics, Inc. | 79.94 Million USD | 77.076% |
| Outset Medical, Inc. | 49.21 Million USD | 62.764% |
| IRIDEX Corporation | 9.9 Million USD | -84.996% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | 53.904% |
| IRadimed Corporation | 12.82 Million USD | -42.933% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -2324.04% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -6828.265% |
| Telesis Bio, Inc. | 4.02 Million USD | -355.298% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -298.012% |
| Varex Imaging Corporation | 277.5 Million USD | 93.396% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -9.453% |
| Dynatronics Corporation | 5.59 Million USD | -227.598% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -389.862% |
| Semler Scientific, Inc. | 445 Thousand USD | -4018.145% |
| InMode Ltd. | 45.09 Million USD | 59.362% |
| Bruker Corporation | 968.3 Million USD | 98.107% |
| Cytosorbents Corporation | 3.68 Million USD | -397.965% |
| DexCom, Inc. | 559.6 Million USD | 96.725% |
| Align Technology, Inc. | 296.9 Million USD | 93.828% |
| Viveve Medical, Inc. | 1.47 Million USD | -1144.956% |
| ZimVie Inc. | 79.6 Million USD | 76.978% |
| Movano Inc. | 1.51 Million USD | -1111.219% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 69.897% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -11615.73% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 88.397% |
| Profound Medical Corp. | 6.95 Million USD | -163.557% |
| Insulet Corporation | 402.6 Million USD | 95.448% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -23.497% |
| iCAD, Inc. | 917 Thousand USD | -1898.445% |
| Nuwellis, Inc. | 1.99 Million USD | -817.664% |
| Biotricity, Inc. | 1.87 Million USD | -875.084% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -31.151% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -770.168% |
| PAVmed Inc. | 1.01 Million USD | -1701.943% |
| BIOLASE, Inc. | 11.43 Million USD | -60.288% |
| Beyond Air, Inc. | 2.12 Million USD | -761.577% |
| FONAR Corporation | 2.71 Million USD | -574.872% |
| AxoGen, Inc. | 23.02 Million USD | 20.392% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | 18.65% |
| Inari Medical, Inc. | 42.9 Million USD | 57.283% |
| UFP Technologies, Inc. | 70.19 Million USD | 73.892% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -2812.644% |
| Tenon Medical, Inc. | 554 Thousand USD | -3207.896% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -1000.827% |
| AdaptHealth Corp. | 113.64 Million USD | 83.874% |
| Sintx Technologies, Inc. | 888 Thousand USD | -1963.71% |
| NanoVibronix, Inc. | 2.73 Million USD | -570.781% |
| Quanterix Corporation | 22.36 Million USD | 18.061% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -23.431% |
| Pacific Biosciences of California, Inc. | 56.67 Million USD | 67.666% |
| TransMedics Group, Inc. | 44.23 Million USD | 58.572% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -224.177% |
| NeuroMetrix, Inc. | 1.55 Million USD | -1075.158% |
| Hyperfine, Inc. | 6.58 Million USD | -178.422% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 77.075% |
| Biomerica, Inc. | 2.37 Million USD | -671.286% |
| Bone Biologics Corporation | -328.84 Thousand USD | 5672.778% |
| AVITA Medical, Inc. | 3.12 Million USD | -487.098% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | 38.661% |